Systematic Reviews
Copyright ©The Author(s) 2023.
World J Gastroenterol. Jan 14, 2023; 29(2): 390-409
Published online Jan 14, 2023. doi: 10.3748/wjg.v29.i2.390
Figure 1
Figure 1 Therapeutic regimens recommended by Maastricht V/Florence consensus report as first-line and second-line treatment. PPI: Proton pump inhibitor.
Figure 2
Figure 2 Preferred Reporting Items for Systematic reviews and Meta-Analyzes flow diagram. H. pylori: Helicobacter pylori.
Figure 3
Figure 3 Third-line triple therapy eradication rates. A: Triple therapy as third line (per protocol); B: Triple therapy as third line (intention to treat).
Figure 4
Figure 4 Triple therapy eradication rates as rescue treatment. A: Triple therapy as rescue treatment (per protocol); B: Triple therapy as rescue treatment (intention to treat).
Figure 5
Figure 5 Third-line quadruple therapy eradication rates. A: Quadruple therapy as third-line treatment (per protocol); B: Quadruple therapy as third-line treatment (intention to treat). BQT: Bismuth quadruple therapy; N-BQT: Non-bismuth quadruple therapy.
Figure 6
Figure 6 Quadruple therapy eradication rates as rescue treatment. A: Quadruple therapy as rescue treatment (per protocol); B: Quadruple therapy as rescue treatment (intention to treat). BQT: Bismuth quadruple therapy; N-BQT: Non-bismuth quadruple therapy.
Figure 7
Figure 7 Recommendation diagram.